Get the app!
Back to Trades

Heyman Tomas J.

DirectorCIK 0001814673

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
3
Buy transactions
0
Sell transactions
0
Companies
3
Active
2025–2026

Heyman Tomas J., Director, accounts for 3 disclosed filings worth $1.8M, spread across 3 companies, active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

3 loaded
May 29EXEL
EXELIXIS, INC.
Heyman Tomas J.DirectorGrant$0
Mar 18LEGN
Legend Biotech Corp
Heyman Tomas J.InsiderOther$0
Dec 9AKRO
Akero Therapeutics, Inc.
Heyman Tomas J.InsiderDisposed$1.8M

3 filings